SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dipyridamole 100mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS NAME OF THE MEDICINAL PRODUCT Digoxin KERN PHARMA 0.25 mg tablets QUALITATIVE AND QUANTITATIVE COMPOSITION Digoxin KERN PHARMA 0.25 mg tablets

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Vitamin A-POS 250 I.U./g, eye ointment, 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

4.1 Therapeutic Indications Supportive therapy for atrophic changes of the cornea and conjunctiva caused by vitamin A deficiency (e.g Keratomalacia, Xerophthalmia) and for trophic disturbances of cornea and conjunctiva caused by mucin deficiency by a well preserved protecting serous film. 4.2 Posology and Method of Administration Instil one strip of eye ointment 3 times daily (especially at nig...

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clarithromycin 500 mg Powder for Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

4.1 Therapeutic indications Clarithromycin 500 mg Powder for solution for Infusion is indicated whenever parenteral therapy is required for treatment of infections caused by susceptible organisms in the following conditions; Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. Upper respiratory tract infections for example, sinusitis and pharyngitis. Skin...

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zyomet 0.75%w/w Gel Metronidazole 0.75%w/w Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

4.2 Posology and method of administration Metronidazole should be applied in a thin layer to the affected areas of the skin twice daily, morning and evening. Areas to be treated should be washed with a mild cleanser before application. Patients may use non comedogenic and non astringent cosmetics after application of metronidazole. The dosage does not need to be adjusted for elderly patients. M...

Shaping medicinal product information: a before and after study exploring physicians’ perspectives on the summary of product characteristics

OBJECTIVE To establish, in the context of the revised European Pharmacovigilance Directive and based on physicians' perspectives, how Summaries of Product Characteristics (SmPCs) could be more user friendly and better support physicians' interactions with patients, thereby improving patients' own understanding of their medicines. DESIGN Qualitative focus group discussions (step 1), developmen...